🔴 Oncolytics Biotech is trading 5% down today

Oncolytics Biotech is trading 5.13% down at $0.76 after no clear company-specific catalyst emerged for the August 10, 2026 decline.

• July’s FDA Fast Track designation is a recent update, not new today.
• July 13 trial-regulatory progress is also not new today.
• The broader market is only modestly weaker, so macro sentiment does not clearly explain the move.